191 related articles for article (PubMed ID: 32807223)
1. Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer.
Ning Y; Zheng H; Zhan Y; Liu S; Yang Y; Zang H; Luo J; Wen Q; Fan S
J Exp Clin Cancer Res; 2020 Aug; 39(1):162. PubMed ID: 32807223
[TBL] [Abstract][Full Text] [Related]
2. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications.
Lakshmanan I; Ponnusamy MP; Macha MA; Haridas D; Majhi PD; Kaur S; Jain M; Batra SK; Ganti AK
J Thorac Oncol; 2015 Jan; 10(1):19-27. PubMed ID: 25319180
[TBL] [Abstract][Full Text] [Related]
3. Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factor-alpha and dexamethasone.
Xu M; Wang X
Cell Biol Toxicol; 2017 Aug; 33(4):361-371. PubMed ID: 28470556
[TBL] [Abstract][Full Text] [Related]
4. Targeting the MET gene for the treatment of non-small-cell lung cancer.
Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
[TBL] [Abstract][Full Text] [Related]
5. Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.
Lappi-Blanco E; Mäkinen JM; Lehtonen S; Karvonen H; Sormunen R; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Kaarteenaho R
Tumour Biol; 2016 Oct; 37(10):13811-13820. PubMed ID: 27481516
[TBL] [Abstract][Full Text] [Related]
6. MUC1 and MUC16: critical for immune modulation in cancer therapeutics.
Chen X; Sandrine IK; Yang M; Tu J; Yuan X
Front Immunol; 2024; 15():1356913. PubMed ID: 38361923
[TBL] [Abstract][Full Text] [Related]
7. Intracellular signals of lung cancer cells as possible therapeutic targets.
Tanaka K; Kumano K; Ueno H
Cancer Sci; 2015 May; 106(5):489-96. PubMed ID: 25707772
[TBL] [Abstract][Full Text] [Related]
8. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer.
Nagai S; Takenaka K; Sonobe M; Ogawa E; Wada H; Tanaka F
J Thorac Oncol; 2006 Jan; 1(1):46-51. PubMed ID: 17409826
[TBL] [Abstract][Full Text] [Related]
9. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract][Full Text] [Related]
10. Mucin gene expression in lung cancer tissues.
Bombardieri E; Seregni E; Lombardo C; Cantoni A; Bogni A; Botti C; Sfreddo L; Cataldo I
Int J Biol Markers; 1994; 9(4):262-3. PubMed ID: 7836808
[No Abstract] [Full Text] [Related]
11. Lamellated mucin concretions mimicking adenocarcinoma.
Khalil MF; Taggart MW; Khazai L
Diagn Cytopathol; 2020 Jul; 48(7):690-691. PubMed ID: 32294299
[No Abstract] [Full Text] [Related]
12. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
Qu Y; Zhao D; Mu J; Che N; Zhang C; Liu Z; Su D; Zhou L; Zhang H; Wei L
Tumour Biol; 2016 Jan; 37(1):887-96. PubMed ID: 26254613
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer.
Yu CJ; Yang PC; Shun CT; Lee YC; Kuo SH; Luh KT
Int J Cancer; 1996 Dec; 69(6):457-65. PubMed ID: 8980247
[TBL] [Abstract][Full Text] [Related]
15. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
18. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
Guddo F; Giatromanolaki A; Koukourakis MI; Reina C; Vignola AM; Chlouverakis G; Hilkens J; Gatter KC; Harris AL; Bonsignore G
J Clin Pathol; 1998 Sep; 51(9):667-71. PubMed ID: 9930070
[TBL] [Abstract][Full Text] [Related]
19. Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.
Ye Z; Shen N; Weng Y; Li K; Hu L; Liao H; An J; Liu L; Lao S; Cai S
Cancer Biol Ther; 2015; 16(7):1071-9. PubMed ID: 25961369
[TBL] [Abstract][Full Text] [Related]
20. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
